Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Caliber Imaging & Diagnostic (LCDX – Research Report) and AstraZeneca (GB:AZN – Research Report).
AstraZeneca (GB:AZN)
J.P. Morgan analyst James Gordon maintained a Buy rating on AstraZeneca yesterday and set a price target of £130.00. The company’s shares closed last Wednesday at p11386.00.
Gordon has an average return of
According to TipRanks.com, Gordon is ranked #3187 out of 8794 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for AstraZeneca with a p11295.36 average price target, a -0.1% downside from current levels. In a report issued on April 8, Barclays also maintained a Buy rating on the stock with a p12500.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
